Global Patient-Controlled Analgesia (PCA) Pump Market Research Report 2022

Due to the COVID-19 pandemic, the global Patient-Controlled Analgesia (PCA) Pump market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Patient-Controlled Analgesia (PCA) Pump market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Patient-Controlled Analgesia (PCA) Pump landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Electronic PCA Pump accounting for % of the Patient-Controlled Analgesia (PCA) Pump global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Patient-Controlled Analgesia (PCA) Pump include Smiths Group plc, Fresenius Kabi Group, Hospira (Pfizer Inc.), Micrel Medical Devices, Ace Medical Co. Ltd, Terumo Corporation, B.Braun Melsungen AG, Baxter International and Becton Dickinson. etc. In terms of revenue, the global 3 largest players have a % market share of Patient-Controlled Analgesia (PCA) Pump in 2021.
This report focuses on Patient-Controlled Analgesia (PCA) Pump volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Patient-Controlled Analgesia (PCA) Pump market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Patient-Controlled Analgesia (PCA) Pump Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Electronic PCA Pump
Mechanical PCA Pump
Segment by Application
Hospitals
Ambulatory Surgical Centers
Home care Settings
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Smiths Group plc
Fresenius Kabi Group
Hospira (Pfizer Inc.)
Micrel Medical Devices
Ace Medical Co. Ltd
Terumo Corporation
B.Braun Melsungen AG
Baxter International
Becton Dickinson